ANI Pharmaceuticals, Alimera Sciences to Close Merger Next Week
ANI Pharmaceuticals (ANIP) and Alimera Sciences (ALIM) said Wednesday that they have scheduled the closing of their merger agreement on Sept. 16.
The closing date was set after Alimera, whose shareholders approved the merger on Sept. 4, said that it filed a lawsuit in the Delaware Court of Chancery to force ANI to complete the merger.
Alimera's shares rose over 6% while ANI's shares fell nearly 3% during recent premarket activity on Wednesday.
Price: 53.90, Change: -1.58, Percent Change: -2.85
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.